REMUS₹901.20-1.59%
Ownership Score
Index Membership
and the weight we carryMutual Fund Ownership
% of each scheme's portfolioInsider & Deals
who traded, and how close they are to the companyREMUS shareholding summary
As of Mar 2026, promoters held 70.95% of REMUS PHARMACEUTICALS L (up 0.04 points from Sep 2025). Institutions together held 6.11%, of which foreign institutional investors held 5.28% (up 0.26 points from Sep 2025) and domestic institutions held 0.83% (up 0.06 points from Sep 2025). The public held the remaining 22.93% (down 0.38 points from Sep 2025). The company had 2,009 shareholders.
| Promoters | 70.95% |
|---|---|
| FII | 5.28% |
| DII | 0.83% |
| Public | 22.93% |